Management Anticipates That it has Sufficiently Addressed the FDA's Concerns to Mitigate the Need for a Clinical Data RequestManagement ...
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDermCohealyx expected to triple AVITA ...
meeting with the U.S. Food and Drug Administration ("FDA") on December 17, 2024, regarding its 510(k) premarket filing submission for the Company's mBôs TKA System (the "Application").
"This meeting reaffirmed our strategic decision to effectuate a multigenerational product strategy and submit the mBôs TKA System for FDA clearance on an accelerated timeline," said Ben Sexson ...
Management Anticipates That it has Sufficiently Addressed the FDA's Concerns to Mitigate the Need for a Clinical Data RequestManagement Anticipates a Comprehensive AIR Response in Q1 2025 AUSTIN, TX / ...
Since the discovery of cell-free DNA (cfDNA) in 1948, shedded DNA fragments have been applied to technologies ranging from pre-natal genetic screening and ...
Intelligent Bio Solutions Inc. (INBS) has submitted a 510(k) premarket notification to the FDA for its Intelligent Fingerprinting Drug Screening System, a rapid and non-invasive drug testing ...
Smith+Nephew earned FDA 510(k) clearance for its Coriograph pre-planning software and modeling services, according to a Dec. 19 news release.
Improving access to nutrition information is an important public health effort the FDA can undertake to help people build healthy eating patterns,” FDA Commissioner Dr. Robert Califf said in a ...
IMUNON announced FDA alignment on CMC strategy for IMNN-001 ... cancer and the competitive landscape for new treatments, the timeline for the upcoming Phase 3 trial may not be aggressive enough ...
NEW YORK (AP) — After days of searching through security footage, following up on a deluge of tips and even sending scuba divers to the bottom of a lake, police on Monday announced the arrest of ...